Niacin
Also known as: nicotinic acid, vitamin B3
Classification
Unknown
Regulatory Status
US prescription extended-release niacin labeling exists for lipid indications. Dietary-supplement niacin status is separate and is not established by this record.
Sources
1
Review
n/a
Overview
Prescription niacin is labeled in lipid management and causes prostaglandin-mediated flushing. This record does not restate a dose.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Benefits
A DailyMed extended-release niacin label describes prescription use in lipid management.
Interactions & cautions
Flagged in source data
statins and other lipid-lowering medicines
Drug interactions
statins and other lipid-lowering medicines — Combining niacin with other lipid-lowering therapy can add muscle and liver monitoring burden. A specific pair outcome is not established here. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw